Hana Pharm Co., Ltd. (KRX:293480)
11,250
-60 (-0.53%)
Last updated: Nov 5, 2025, 1:47 PM KST
Hana Pharm Market Cap
Hana Pharm has a market cap or net worth of 201.01 billion as of November 5, 2025.
Market Cap
201.01B
Enterprise Value
n/a
Revenue
139.33B
Ranking
n/a
PE Ratio
5.04
Stock Price
11,250.00
Market Cap Chart
Since October 2, 2018, Hana Pharm's market cap has decreased from 537.03B to 201.01B, a decrease of -62.57%. That is a compound annual growth rate of -12.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 201.01B | 3.76% |
| Dec 30, 2024 | 193.73B | -21.86% |
| Dec 28, 2023 | 247.93B | -23.56% |
| Dec 29, 2022 | 324.36B | -9.43% |
| Dec 30, 2021 | 358.12B | -14.15% |
| Dec 30, 2020 | 417.15B | 14.19% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 56.52T |
| Celltrion | 38.68T |
| ALTEOGEN | 26.13T |
| SK Biopharmaceuticals | 9.05T |
| Yuhan | 8.83T |
| HLB Co., Ltd. | 6.38T |
| Peptron | 6.31T |
| PharmaResearch | 5.62T |